Navigation Links
aTyr Pharma Raises an Additional $12 Million
Date:7/28/2009

pital groups in the biotechnology industry."

Based in San Diego, aTyr Pharma has a majority owned subsidiary in China, Pangu BioPharma. Discovery efforts at Pangu BioPharma are based at the Hong Kong University of Science and Technology, with matching funding provided by the Hong Kong Government's Innovation and Technology Fund. Encouragement of biotechnology development by both the Chinese and Hong Kong governments allows aTyr Pharma to leverage investor dollars in the global economy, while at the same time offering the experienced leadership of a proven team to building biotechnology in Asia. Professor Schimmel points out, "The decision to have an Asian presence for aTyr Pharma was driven by our recognition of the progress China has made in meeting international standards while capitalizing on government support for building biotechnology in China. Pangu BioPharma has already identified multiple resectins for our discovery engine, increasing the number of drug candidates with the potential to treat a wide variety of diseases. While we expand our discovery and preclinical platforms in both San Diego and China, it is important for us to have funding for development of our lead candidate to confirm the therapeutic potential for our product class. This new round of financing from our investors is a gratifying endorsement of aTyr Pharma's discovery and development efforts."

About Alta Partners

Alta Partners is a San Francisco-based venture capital firm focused on life sciences investing. Founded in 1996, the firm has raised $2 billion in committed capital through eight venture fund programs. Alta invests in life sciences companies across the development continuum, from company formation to later-stage opportunities, and has funded more than 130 companies in the sector to date.

www.altapartners.com

Abo
'/>"/>

SOURCE aTyr Pharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Fifty percent of adults who seek ... twenty percent of Americans claim to have fatigue that ... Adrenal Fatigue is the most common yet overlooked cause ... classic symptoms. Tasks that were once a breeze are ... didn’t cause irritation, experiencing weight gain around the middle ...
(Date:8/28/2014)... Doctors Frank DellaCroce and Scott Sullivan, ... (CRBS) and the St. Charles Surgical Hospital ... that board certified surgeon Dr. Craig Ashley Blum has ... to reconstructive breast surgery. Blum will work with the ... Trahan, and M. Whitten Wise. , “We are excited ...
(Date:8/28/2014)... August 29, 2014 Involution ... some of the healthcare industry's most pressing problems, ... radically rethink health. Involution Studios' creative team ... creating software solutions for clients including AstraZeneca, 3M ... As part of the studio's philosophy to change ...
(Date:8/28/2014)... Starting on Monday, the Mesothelioma Applied ... in Bitcoin, in addition to all the traditional ways ... at http://www.curemeso.org/bitcoin . , “As more and ... payment, we decided it was important for us to ... Melinda Kotzian. , Bitcoin is an online-only, internet ...
(Date:8/28/2014)... Skmen.com, one of the most popular suppliers of men’s ... long sleeve sweater dresses and launched a ... unveiled sweater outfits are available at discounted rates, up ... of fact, Skmen.com’s fashionable and quality items have greatly ... company’s experienced tailors are striving to make more incomparable ...
Breaking Medicine News(10 mins):Health News:Peoria AlignLife Clinics Focus on Community Education 2Health News:New Plastic Surgeon Joins Center For Restorative Breast Surgery 2Health News:Top Three Open Source Design Concepts that Rethink Health from Involution Studios 2Health News:Top Three Open Source Design Concepts that Rethink Health from Involution Studios 3Health News:Cancer Research Funding Organization Now Accepts Bitcoin Donations 2Health News:Skmen.com: Bestselling Long Sleeve Sweater Dresses Are Offered Online Now 2
... Findings suggest airway pressure treatment prevents complications, cuts readmissions ... hours of postoperative treatment with continuous positive airway pressure ... heart surgery, finds a new study. , CPAP is ... study, published in the May issue of Chest ...
... discovered gene known as DEAR1 is mutated in breast cancer ... early-onset breast cancer, a research team headed by scientists at ... in the journal PLoS Medicine . , "The ... women have recurrences in the breast, and cancers that do ...
... $1.5 Million - $3 MillionPRINCETON, N.J., May 6 ... DSCI), a manufacturer and marketer of advanced wound care products, ... private label adhesive bandages to one of the largest medical ... are expected to range between $1.5 to $3.0 million for ...
... conference focused on promoting physical activity on college ... on connecting health care providers and the public ... infiltrating college campuses nationwide. The American College of ... On Campus," a program component to address and ...
... --Leadership in Fight Against Tobacco Recognized Nationally--WASHINGTON, May ... has been named the South Regional Youth Advocate ... Kids for her leadership in the fight against ... in the nation,s capital tonight (May 6) along ...
... has potent anti-inflammatory properties and British scientists have now found that ... substance feared in biologic warfare. , ... Manhasset, NY ... British scientists have now found that it is helpful in delaying ...
Cached Medicine News:Health News:Novel gene predicts local recurrence in early onset breast cancer 2Health News:Novel gene predicts local recurrence in early onset breast cancer 3Health News:Derma Sciences Announces New Contract With Major Medical Products Supplier for Private Label Adhesive Bandages 2Health News:Derma Sciences Announces New Contract With Major Medical Products Supplier for Private Label Adhesive Bandages 3Health News:'Exercise is Medicine On Campus' Launches With National Call to Action 2Health News:'Exercise is Medicine On Campus' Launches With National Call to Action 3Health News:Campaign for Tobacco-Free Kids Honors Colleen Daly of Asheville, NC As Youth Advocate of the Year 2Health News:Nicotine May Help Prevent Damage from Bioterrosim Toxin and Growth Factors in Heart Disease News from Molecular Medicine 2
(Date:8/28/2014)... Aug. 28, 2014 /PRNewswire-iReach/ -- CountryFocus: Healthcare, Regulatory ... (Photo - http://photos.prnewswire.com/prnh/20140828/140879 ) ... Regulatory and Reimbursement Landscape Poland " an essential ... in the healthcare market and provides insights into ... Most importantly, the report provides valuable insights into ...
(Date:8/28/2014)... Resources Group finds that the market for colorectal cancer (CRC) ... in the United States , ... Italy , Spain , the ... . The biosimilar erosion of Roche/Genentech/Chugai,s Avastin and Bristol-Myers Squibb/Eli ... of Eli Lilly,s Cyramza, Taiho Pharmaceutical,s Lonsurf, Alchemia,s HA-irinotecan and ...
(Date:8/28/2014)... CHARLOTTE, N.C. , Aug. 28, 2014 /PRNewswire/ ... innovation marketplace, today announced a worldwide search for ... of the senior population.  Promising ideas uncovered through ... presented to leading medical device manufacturers and healthcare ... to improve the lives of individuals age 65 ...
Breaking Medicine Technology:Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3
... ... , ... , , , ... ...
... , ... ... ... ...
Cached Medicine Technology:Smith & Nephew Orthopaedics Launches Versatile VLP(TM) FOOT Plating System 2Smith & Nephew Orthopaedics Launches Versatile VLP(TM) FOOT Plating System 3Smith & Nephew Orthopaedics Launches Versatile VLP(TM) FOOT Plating System 4Smith & Nephew Orthopaedics Launches Versatile VLP(TM) FOOT Plating System 5An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists 2An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists 3An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists 4An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists 5An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists 6
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: